Pediatric Endocrinology Research

Type 1 Diabetes Studies

• TrialNet Pathway to Prevention of Type 1 Diabetes, active enrolling
• TrialNet HYDROXYCHLOROQUINE FOR PREVENTION OF ABNORMAL GLUCOSE TOLERANCE AND DIABETES IN INDIVIDUALS AT-RISK FOR TYPE 1 DIABETES MELLITUS, active, enrolling
• TrialNet CTLA-4 Ig (Abatacept) FOR PREVENTION OF ABNORMAL GLUCOSE TOLERANCE AND DIABETES IN RELATIVES AT-RISK FOR TYPE 1 DIABETES MELLITUS, active, closed to enrollment
• Long-Term Investigative Follow-up in TrialNet, active, enrolling

Contact Us

Here are some other helpful sites for research activities at the University of Utah.

https://uofuhealth.utah.edu/diabetes-metabolism-research-center/

https://cfahr.utah.edu

https://medicine.utah.edu/research/

https://medicine.utah.edu/internalmedicine/endocrinology/research/faculty-research.php

Research, Clinical Trials and Quality Improvement Projects in the Division of Pediatric Endocrinology at the University of Utah 

1. Incidence of autoimmune thyroid disease in Type 1 diabetes. Mark Hamaker M.D.; Dania Al-Hamad, M.B.B.S 
2. Trial Net Pathway to Prevention. Zoe Raleigh, M.D.; Vandana Raman, M.D; Allison Smego, M.D. 
3. TN22 Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus. Vandana Raman, M.D.; Zoe Raleigh, M.D. 
4. TN10 Teplizumab for Prevention of Type 1 Diabetes in Relatives At-Risk.  Vandana Raman, M.D.; Zoe Raleigh, M.D. 
5. TN18 CTLA4-Ig (Abatacept) for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At-Risk for Type 1 Diabetes. Vandana Raman, M.D.; Zoe Raleigh, M.D. 
6. TN16 Long-Term Investigative Follow-up (LIFT) in Trial Net. Zoe Raleigh, M.D.; Vandana Raman, M.D. 
7. Patient Knowledge of Insulin Pump Failure Management among Youth with Type 1 Diabetes. Zoe Raleigh, M.D.; Vandana Raman, M.D. 
8. Management of Severe Diabetic Ketoacidosis outside of the Pediatric Intensive Care Unit. Zoe Raleigh, M.D; Vandana Raman, M.D. 
9. Review of cases of primary congenital hypothyroidism identified on newborn screening in Utah from 2010-2016. Zoe Raleigh, M.D; Mary Murray, M.D. 
10. Efficacy of Growth Attenuation Therapy in Utah from 2008-2019. Zoe Raleigh, M.D; Mary Murray, M.D. 
11. Individualized Multidisciplinary Treatment and Intensive Diabetes Management in Adolescents with Poorly Controlled Type 1 Diabetes Mellitus. Vandana Raman, M.D.; Sara Turner, PhD 
12. Healthcare disparity in use of Technology in T1DM. Hannah Jelley, M.D.; Michelle Meder, M.D.; Vandana Raman M.D. 
13. Management of hypoglycemia in the Pediatric Emergency Department. Hannah Jelley, M.D.; Michelle Meder, M.D. Vandana Raman, M.D.; Scott Clements M.D. 
14. Subcutaneous insulin management of pediatric type 1 diabetes in mild to moderate DKA: a retrospective study. Michelle Meder, M.D.; Hannah Jelley, M.D; Allison Smego, M.D. 
15. Fellows as Medical Educators (FAME): Longitudinal Curriculum. Kathleen Timme, M.D. 
16. Importance of Promotion Criteria for Clinical Educators. Kathleen Timme, M.D. 
17. Students as teachers: Longitudinal Pathway. Kathleen Timme, M.. 
18. Online asynchronous trainee-as-teacher curriculum. Kathleen Timme, M.D. 
19. Management and Treatment of Pediatric Type 2 Diabetes. Care Process Model. Intermountain Healthcare. Allison Smego, M.D. 
20. Diagnosis and Treatment of Pediatric Type 1 Diabetes. Care Process Model. Allison Smego, M.D. 
21. CARE PWS: Phase 3, Randomized, Double-Blind, Placebo-Controlled, 8-week Clinical Study to Assess the Efficacy, Safety, and Tolerability, of Intranasal Carbetocin (LV-101) in Prader-Willi Syndrome (PWS) with Long Term Follow-Up. Scott Clements M.D. 
22. Type 1 diabetes (T1D) incidence trends in Utah among children less than age 19 years from 2001 to 2015. Scott Clements, M.D.